Last reviewed · How we verify
Glutathione supplementation
At a glance
| Generic name | Glutathione supplementation |
|---|---|
| Also known as | Gluthathione Peroxidates, GSH |
| Sponsor | Milton S. Hershey Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients. (PHASE1)
- Glutathione in Mild Cognitive Impairment (EARLY_PHASE1)
- Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation (PHASE1)
- A Study of Glutathione in Children With Autism Spectrum Disorder (PHASE4)
- Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment (NA)
- The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients (NA)
- Effect of Vitamin D Supplementation on Glutathione Peroxidase (GPx) Activity, Interleukin-6 (IL-6) Levels and Clinical Outcomes in Post-COVID-19 Patients (NA)
- Effectiveness and Safety of Two Vitamin D3 Supplementation Regimens in Adults with Early-stage COVID-19 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glutathione supplementation CI brief — competitive landscape report
- Glutathione supplementation updates RSS · CI watch RSS
- Milton S. Hershey Medical Center portfolio CI